Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
City of Hope Medical Center
Stanford University
City of Hope Medical Center
City of Hope Medical Center
Servier
M.D. Anderson Cancer Center
Therapeutic Advances in Childhood Leukemia Consortium
Emory University
University of Washington
Ohio State University Comprehensive Cancer Center
Zhejiang University
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Massachusetts General Hospital
University of Maryland, Baltimore
Milton S. Hershey Medical Center
Abramson Cancer Center at Penn Medicine
Dana-Farber Cancer Institute
Case Comprehensive Cancer Center
City of Hope Medical Center
Stanford University
University of Pittsburgh
Massachusetts General Hospital
Stanford University
University of Pittsburgh
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Sanofi
Barbara Ann Karmanos Cancer Institute
Washington University School of Medicine
University Hospital, Lille
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
University of California, San Francisco
St. Jude Children's Research Hospital
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Northwestern University
Northwestern University
National Institutes of Health Clinical Center (CC)
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)